Technological advances in the assessment of impulse control in offenders: A systematic review.


Journal

Behavioral sciences & the law
ISSN: 1099-0798
Titre abrégé: Behav Sci Law
Pays: United States
ID NLM: 8404861

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 06 07 2018
revised: 30 10 2018
accepted: 02 11 2018
pubmed: 4 7 2019
medline: 24 9 2019
entrez: 4 7 2019
Statut: ppublish

Résumé

Deficits in impulse control have been linked to criminal offending, risk of recidivism, and other maladaptive behaviours relevant to the criminal justice system (e.g. substance use). Impulse control can be conceptualized as encompassing the broad domains of response inhibition and impulsive/risky decision-making. Advancements in technology have led to the development of computerized behavioural measures to assess performance in these domains, such as go/no-go and delay discounting tasks. Despite a relatively large literature examining these tasks in offenders, findings are not universally consistent. This systematic review aims to synthesize the literature using computerized neurocognitive tasks to assess two domains of impulse control in offenders: response inhibition and impulsive/risky decision-making. The review included 28 studies from diverse geographic locations, settings, and offender populations. The results largely support the general conclusion that offenders exhibit deficits in impulse control compared with non-offenders, with studies of response inhibition more consistently reporting differences than studies using impulsive and risky decision-making tasks. Findings are discussed in the context of contemporary neuroimaging research emphasizing dysfunction in prefrontal cortex as a key contributor to impulse control deficits in offenders.

Identifiants

pubmed: 31268203
doi: 10.1002/bsl.2420
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-451

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Lana Vedelago (L)

Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, ON, Canada.

Michael Amlung (M)

Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, ON, Canada.
Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University, Hamilton, ON, Canada.

Vanessa Morris (V)

Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, ON, Canada.

Tashia Petker (T)

Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, ON, Canada.

Iris Balodis (I)

Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, ON, Canada.
Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University, Hamilton, ON, Canada.

Kaitlyn McLachlan (K)

Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, ON, Canada.
Department of Psychology, University of Guelph, Guelph, ON, Canada.

Mini Mamak (M)

Forensic Psychiatry Program, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.

Heather Moulden (H)

Forensic Psychiatry Program, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.

Gary Chaimowitz (G)

Forensic Psychiatry Program, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.

James MacKillop (J)

Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, ON, Canada.
Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University, Hamilton, ON, Canada.
Homewood Research Institute, Guelph, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH